Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Seriu

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Hematology|May 31, 2003
Size and composition of T-cell receptor delta (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemiaTaku Seriu, Yvonne Stark, Dorothee Erz, et al.
Cancer Science|July 26, 2011
Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumorsShunji Takahashi, Masaki Miyazaki, Isamu Okamoto, et al.
Anticancer Research|April 1, 2009
Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in JapanJun Horiguchi, Yoshiaki Rai, Kazuo Tamura, et al.
Japanese Journal of Clinical Oncology|February 14, 2012
A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancerMegumi Ishiguro, Toshiaki Watanabe, Kensei Yamaguchi, et al.
Diagnostic Microbiology and Infectious Disease|April 26, 2011
Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patientsHiroyuki Yoshitsugu, Takao Sakurai, Hiroki Ishikawa, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2010
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapyKen Kato, Makoto Tahara, Shuichi Hironaka, et al.
Leukemia Research|May 20, 2011
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemiaSeisho Takeuchi, Masahide Matsushita, Martin Zimmermann, et al.
Journal of Gastroenterology and Hepatology|June 17, 2008
Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patientsFumitaka Suzuki, Joji Toyoda, Yoshiaki Katano, et al.
Journal of Gastroenterology and Hepatology|February 14, 2009
Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in JapanHaruhiko Kobashi, Kouichi Takaguchi, Hiroshi Ikeda, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|January 1, 2004
[Dose investigation of superparamagnetic iron oxide (SPIO) SH U 555 A in liver MR imaging]Shinji Hirohashi, Tomoaki Ichikawa, Akihiro Tanimoto, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Hematology|May 31, 2003
Size and composition of T-cell receptor delta (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemiaTaku Seriu, Yvonne Stark, Dorothee Erz, et al.
Cancer Science|July 26, 2011
Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumorsShunji Takahashi, Masaki Miyazaki, Isamu Okamoto, et al.
Anticancer Research|April 1, 2009
Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in JapanJun Horiguchi, Yoshiaki Rai, Kazuo Tamura, et al.
Japanese Journal of Clinical Oncology|February 14, 2012
A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancerMegumi Ishiguro, Toshiaki Watanabe, Kensei Yamaguchi, et al.
Diagnostic Microbiology and Infectious Disease|April 26, 2011
Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patientsHiroyuki Yoshitsugu, Takao Sakurai, Hiroki Ishikawa, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2010
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapyKen Kato, Makoto Tahara, Shuichi Hironaka, et al.
Leukemia Research|May 20, 2011
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemiaSeisho Takeuchi, Masahide Matsushita, Martin Zimmermann, et al.
Journal of Gastroenterology and Hepatology|June 17, 2008
Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patientsFumitaka Suzuki, Joji Toyoda, Yoshiaki Katano, et al.
Journal of Gastroenterology and Hepatology|February 14, 2009
Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in JapanHaruhiko Kobashi, Kouichi Takaguchi, Hiroshi Ikeda, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|January 1, 2004
[Dose investigation of superparamagnetic iron oxide (SPIO) SH U 555 A in liver MR imaging]Shinji Hirohashi, Tomoaki Ichikawa, Akihiro Tanimoto, et al.
Pageof 3